slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
100,4 PKR | +2,43% | +9,73% | +20,98% |
Vakgebied
Aantal werknemers: 1 700
Verkoop per activiteit
PKR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 41 842 | 100,0 % | 49 661 | 100,0 % | +18,69% |
Verkoop per regio
PKR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pakistan
100,0
%
| 41 842 | 100,0 % | 49 661 | 100,0 % | +18,69% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | - | 01-03-20 | |
Hasham Ali Baber
DFI | Director of Finance/CFO | - | 01-06-21 |
Chief Tech/Sci/R&D Officer | - | - | |
Chief Tech/Sci/R&D Officer | - | - | |
Ovais Farooq
AUD | Comptroller/Controller/Auditor | - | 23-05-22 |
Tariq Farooq
PRN | Corporate Officer/Principal | - | - |
Gohar Nayab Khan
LAW | General Counsel | - | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Muneer Kamal
BRD | Director/Board Member | 70 | 02-04-20 |
Maheen Rahman
BRD | Director/Board Member | - | 05-12-18 |
Chief Executive Officer | - | 01-03-20 | |
Director/Board Member | - | 07-05-11 | |
Hasham Ali Baber
DFI | Director of Finance/CFO | - | 01-06-21 |
Simon Foster
BRD | Director/Board Member | - | 28-09-22 |
Kuen Goh Lai
CHM | Chairman | - | 05-08-22 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 318 467 278 | 45 032 162 ( 14,14 %) | 0 | 14,14 % |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+20,98% | 115 mln. | |
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |
- Beurs
- Aandelen
- Koers GLAXO
- Onderneming GlaxoSmithKline Pakistan Limited